Wealth Enhancement Advisory Services
ORIC icon

Wealth Enhancement Advisory Services’s Oric Pharmaceuticals ORIC Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$184K Buy
16,949
+5,202
+44% +$47.2K ﹤0.01% 3620
2026
Q1 		$104K Buy
+11,747
New +$133K ﹤0.01% 3310
2025
Q4 		– Sell
-10,002
Closed -$141K – 3761
2025
Q3 		$141K Buy
+10,002
New +$105K ﹤0.01% 3256

Other funds holding ORIC

TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

Wealth Enhancement Advisory Services's ORIC Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Oric Pharmaceuticals (ORIC) stake by 44% in Q2 2026, buying an estimated $47.2K and bringing the position to 16,949 shares worth $184K. The position accounts for ﹤0.01% of the portfolio, ranked #3620.

Wealth Enhancement Advisory Services first reported a position in ORIC in Q3 2025 and has held it in 3 quarters since. 15 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • Wealth Enhancement Advisory Services held 16,949 shares of Oric Pharmaceuticals worth $184K as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 5,202 Oric Pharmaceuticals shares in Q2 2026, an estimated $47.2K.
  • Oric Pharmaceuticals made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3620 holding.
  • Wealth Enhancement Advisory Services first reported a position in Oric Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 15 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.